• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (5): 882-894.DOI: 10.3969/j.issn.1671-2587.2026.05.028

• 综述 • 上一篇    

肝素诱导的血小板减少症临床特点及实验室检测研究进展*

陈甜甜1, 邱进2, 李菲2, 陈伟2   

  1. 1新疆维吾尔自治区人民医院白鸟湖医院,新疆乌鲁木齐 830022;
    2新疆维吾尔自治区人民医院,新疆乌鲁木齐 830001
  • 收稿日期:2026-09-03 修回日期:2026-09-18 出版日期:2026-10-20 发布日期:2026-11-11
  • 通讯作者: 陈伟,主要从事输血医学与免疫血液学研究,(E-mail)29286889@qq.com。
  • 作者简介:陈甜甜,主要从事输血医学与免疫血液学研究,(E-mail)1084113253@qq.com。
  • 基金资助:
    *本课题受新疆维吾尔自治区“天山英才”医药卫生高层次人才项目(No.TSYC202401B157)、新疆第二医学院科研项目(No.ZR202624)、新疆维吾尔自治区人民医院白鸟湖医院院内项目(No.BNH-Y202601)资助

Heparin-Induced Thrombocytopenia: Clinical Characteristics and Research Progress in Laboratory Diagnostics

CHEN Tiantian1, QIU Jin2, LI Fei2, CHEN Wei2   

  1. 1Xinjiang Uygur Autonomous Region People's Hospital Bainiao Lake Hospital, Urumqi 830022;
    2Xinjiang Uygur Autonomous Region People's Hospital, Urumqi 830001
  • Received:2026-09-03 Revised:2026-09-18 Online:2026-10-20 Published:2026-11-11

摘要: 肝素诱导的血小板减少症(HIT)是肝素类药物引起的严重免疫不良反应,主要由抗血小板因子4(PF4)-肝素复合物IgG抗体介导,以血小板计数进行性下降及血栓形成风险增加为特征。临床上HIT主要分为Ⅰ型和Ⅱ型两种,其中Ⅱ型危害较大,若未及时诊治,严重时可导致患者残疾甚至死亡。目前临床多采用4Ts评分结合实验室检查进行诊断,其中免疫筛查试验的检测灵敏度高但特异性较差。5-羟色胺释放试验(SRA)是目前公认的功能学金标准(灵敏度90%~95%,特异性>98%)。近年来,随着检验技术的不断发展,自动化化学发光免疫检测、新型快速功能试验、流式细胞技术等新技术的逐步应用,优化了HIT的诊断流程。本文系统梳理了HIT的发病特点、临床分型及典型症状,对比各类HIT实验室检测方式的利弊点及最新研究进展,以期能为临床快速识别HIT、精准开展检验工作提供一定的参考。

关键词: 肝素诱导血小板减少症, 实验室诊断, 血小板功能确证试验, PF4-肝素抗体, 血栓并发症, 临床分型

Abstract: Heparin-induced thrombocytopenia (HIT) is a severe immune-mediated adverse reaction caused by heparin drugs, primarily mediated by anti-platelet factor 4 (PF4)-heparin complex IgG antibodies, and characterized by progressive thrombocytopenia and increased risk of thrombosis. Clinically, HIT is mainly classified into two types: type Ⅰ and type Ⅱ, with type Ⅱ being more harmful. If not diagnosed and treated promptly, it can lead to patient disability or even death. Currently, clinical diagnosis primarily relies on the 4Ts score combined with laboratory tests, among which immunological screening assays have high sensitivity but relatively low specificity. The serotonin release assay (SRA) is currently recognized as the functional gold standard for HIT diagnosis (with a sensitivity of 90%~95% and specificity greater than 98%). In recent years, with the continuous development of laboratory technology, the progressive application of new technologies such as automated chemiluminescence immunoassay, novel rapid functional assays, and flow cytometry, has optimized the diagnostic workflow for HIT. This article systematically reviews the pathogenic features, clinical classification, and typical symptoms of HIT, and compares the advantages and disadvantages of various HIT laboratory detection methods, as well as the latest research advances in these fields, aiming to provide a reference for rapid clinical identification of HIT and precise laboratory testing.

Key words: Heparin-induced thrombocytopenia, Laboratory diagnosis, Platelet functional confirmatory test, PF4-heparin antibody, Thrombotic complications, Clinical classification

中图分类号: